A股股票代码：601336 A股股票简称：新华保险 编号：2025-026号 H股股票代码： 01336 H股股票简称：新华保险 新华人寿保险股份有限公司 关于对外投资的公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准 确性和完整性承担法律责任。 重要内容提示： 投资标的情况：新华人寿保险股份有限公司（以下简称"本公司"）拟出 资不超过 100 亿元（含)（人民币，下同）认购由国丰兴华（北京）私募基 金管理有限公司（以下简称"国丰兴华"或"基金管理人"）发起设立的私 募基金（以下简称"基金"或"私募基金"）的份额。 相关风险提示：截至本公告发布日，本公司及相关方尚未就认购基金份 额完成合同签署，合同内容以各方最终签署的正式合同为准；设立基金尚 需履行基金备案等监管相关手续，具体实施情况和进度存在一定的不确定 性。 一、对外投资概述 1、对外投资基本情况 为积极响应国家推动中长期资金入市的政策理念，贯彻长期投资理念，通过 低频交易、长期持有的方式以获得稳健股息收益，提升长期投资回报，实现资金 保值增值，本公司拟出资不超过 100 亿 ...

数据统计显示，中证港股通非银行金融主题指数近一个月下跌5.99%，近三个月上涨2.53%，年至今上 涨0.89%。 据了解，中证港股通非银行金融主题指数从港股通证券范围中选取符合非银行金融主题的不超过50家上 市公司证券作为指数样本，以反映港股通范围内非银行金融主题上市公司的整体表现。该指数以2014年 11月14日为基日，以3000.0点为基点。 从指数持仓来看，中证港股通非银行金融主题指数十大权重分别为：香港交易所（17.05%）、中国平 安（15.05%）、友邦保险（14.84%）、中国人寿（7.95%）、中国财险（7.32%）、中国人民保险集团 （5.79%）、中国太保（5.22%）、新华保险（4.85%）、中信证券（2.62%）、中国太平（2.55%）。 从中证港股通非银行金融主题指数持仓的市场板块来看，香港证券交易所占比100.00%。 金融界4月29日消息，上证指数低开震荡，中证港股通非银行金融主题指数 (港股通非银，931024)下跌 0.07%，报2930.08点，成交额75.14亿元。 从中证港股通非银行金融主题指数持仓样本的行业来看，保险占比65.20%、其他资本市场占比 21.56%、 ...

南财快讯记者注意到，这并非新华保险和中国人寿首次合作。 4月29日晚间，新华保险发布对外投资公告称，为提升长期投资回报，实现资金保值增值，拟出资不超 过100亿元认购由国丰兴华（北京）私募基金管理有限公司（简称"国丰兴华"）发起设立的私募基金的 份额。 据披露，国丰兴华发起设立的基金为国丰兴华鸿鹄志远二期私募证券投资基金（暂定名，简称"鸿鹄志 远二期"），存续期限为10年，按照基金合同约定履行相应变更手续后，私募基金存续期限可以相应延 长。该基金将贯彻长期投资理念，通过低频交易、长期持有的方式以获得稳健股息收益。 需要指出的是，另一保险巨头中国人寿也将出资100亿元认购鸿鹄志远二期份额，届时基金成立规模可 达200亿元。 私募基金投资范围方面，要求为中证A500指数成分股中符合条件的大型上市公司A+H股。此外，标的 公司应当公司治理良好、经营运作稳健、股息相对稳定、股票流动性相对较好，与保险资金长期投资需 求相适应。 公告显示，国丰兴华成立于2023年，注册资本1000万元，由新华保险控股子公司新华资产管理股份有限 公司与中国人寿资产管理公司共同出资设立，分别持有国丰兴华50%股权。 2023年11月，新华保 ...

第二批保险资金长期投资改革试点又见进展。 4月29日，新华保险披露，拟出资100亿元认购由国丰兴华（北京）私募基金管理有限公司发起设立的私募基金 的份额。基金名称为国丰兴华鸿鹄志远二期私募证券投资基金（暂定名，下称"鸿鹄二期基金"）。 鸿鹄二期基金成立规模200亿元，新华保险与中国人寿拟各出资100亿元认购基金份额。 券商中国记者此前从中国太保处了解到，在获得监管同意试点的批复后，中国太保集团组织旗下太保寿险和太 保资产两家子公司积极推动具体事项落地。目前，设立私募基金公司相关申报材料已经报送金融监管总局。 公告称，鸿鹄二期基金为权益类私募证券投资基金，投资范围为中证A500指数成份股中符合条件的大型上市 公司A+H股。标的公司应当公司治理良好、经营运作稳健、股息相对稳定、股票流动性相对较好，与保险资 金长期投资需求相适应。若基金有闲置资金，可投资于货币市场基金、银行存款、国债逆回购等现金管理类投 资品种。 该基金存续期限为10年，按照基金合同约定履行相应变更手续后，私募基金存续期限可以相应延长。 对于这项投资，新华保险表示，为积极响应国家推动中长期资金入市的政策理念，贯彻长期投资理念，通过低 频交易、长期持 ...

Group 1 - The core viewpoint of the news is that insurance capital is actively entering the market, with New China Life Insurance planning to invest up to 10 billion yuan in a private fund initiated by Guofeng Xinghua [1][3][4] - The private fund, tentatively named "Honghu Zhiyuan Phase II," has a total scale of 20 billion yuan, with both New China Life and China Life Insurance each contributing 10 billion yuan [3][4] - The investment strategy of the fund focuses on long-term investment, aiming for stable dividend income and capital appreciation through low-frequency trading and long-term holding [3][4] Group 2 - The fund will invest in large listed companies that are part of the CSI A500 index, specifically targeting A+H shares that meet certain criteria [3][4] - New China Life's investment aligns with national policies promoting long-term capital market participation and reflects the company's strategic direction towards long-term, value, and prudent investments [4] - The Honghu Fund, a previous initiative by New China Life and China Life, has successfully invested 50 billion yuan and achieved performance exceeding benchmarks, indicating a positive trend in insurance capital investments [4] Group 3 - The Honghu Fund has increased its holdings in Shaanxi Coal and maintained its position in China Telecom, becoming a significant shareholder in both companies [5][6] - As of the first quarter of 2025, the Honghu Fund held 116.34 million shares of Shaanxi Coal, with a market value of 2.30 billion yuan, despite a decline in stock price [5] - The fund also holds 76.17 million shares of China Telecom, with a market value of 5.98 billion yuan, reflecting a stable investment strategy amidst market fluctuations [6]

险资入市又有了新进展。 4月29日晚，新华保险公告称，公司拟出资不超过100亿元认购由国丰兴华（北京）私募基金管理有限公司发起 设立的私募基金的份额。该基金成立规模为200亿元，新华保险与中国人寿拟各出资100亿元认购私募基金份 额。 公告显示，该基金投资范围为中证A500指数成份股中符合条件的大型上市公司A+H股。 据了解，该私募基金的名称暂定为国丰兴华鸿鹄志远二期私募证券投资基金（简称"鸿鹄志远二期"），由国丰 兴华发起设立。鸿鹄志远二期存续期限为10年，私募基金贯彻长期投资理念，通过低频交易、长期持有的方式 以获得稳健股息收益。 鸿鹄志远二期的规模为200亿元，新华保险与中国人寿拟各出资100亿元认购私募基金份额。基金投资范围为， 中证A500指数成 份 股中符合条件的大型上市公司A+H股。 据新华保险公告，鸿鹄志远二期的投资标的应当公司治理良好、经营运作稳健、股息相对稳定、股票流动性相 对较好，与保险资金长期投资需求相适应。 新华保险表示，本次投资事项符合国家推动中长期资金入市的相关政策，以及未来本公司整体战略发展方向。 本公司坚持长期投资、价值投资和稳健投资的理念，积极发挥好长期资本、耐心资本、高能 ...

Financial Performance - The company reported a revenue of RMB 33,402 million for Q1 2025, representing a 26.1% increase compared to RMB 26,479 million in the same period last year[8]. - Net profit attributable to shareholders reached RMB 5,882 million, up 19.0% from RMB 4,942 million year-on-year[8]. - The consolidated operating revenue for the three months ended March 31, 2025, was RMB 33,402 million, representing a 26.2% increase from RMB 26,479 million in the same period of 2024[26]. - The net profit attributable to shareholders of the parent company for the three months ended March 31, 2025, was RMB 5,882 million, up 19.2% from RMB 4,942 million in the same period of 2024[27]. - The basic and diluted earnings per share for the three months ended March 31, 2025, were both RMB 1.89, compared to RMB 1.58 for the same period in 2024[27]. - The total comprehensive income for the three months ended March 31, 2025, was RMB (16,356) million, compared to RMB (11,061) million in the same period of 2024[27]. Business Growth - The company's new business value increased by 67.9% year-on-year, driven by a significant rise in first-year premium income[15]. - The first-year premium income for long-term insurance was RMB 27,236 million, a remarkable growth of 149.6% compared to the previous year[15]. - The first-year premium for long-term insurance in the individual insurance channel grew significantly by 149.6% to RMB 27,236 million from RMB 10,910 million year-on-year[18]. - The bancassurance channel achieved a premium income of RMB 26,889 million, marking a 69.4% increase from RMB 15,875 million in the previous year[20]. - The first-year premium for long-term insurance in the bancassurance channel increased by 168.2% to RMB 15,057 million from RMB 5,615 million year-on-year[20]. - The company reported a 298.4% increase in single premium income for long-term insurance, reaching RMB 7,765 million compared to RMB 1,949 million in the previous year[18]. - The group insurance channel's premium income rose by 18.6% to RMB 1,776 million, with short-term insurance premiums increasing by 13.8% to RMB 1,530 million[19]. - The average monthly performance of the high-quality marketing team in the individual insurance channel showed a double-digit growth year-on-year[18]. - The company is focusing on enhancing its marketing capabilities and optimizing its business structure to drive future growth[19]. Assets and Liabilities - The total assets of the company at the end of the reporting period were RMB 1,753,416 million, reflecting a 3.6% increase from RMB 1,692,297 million at the end of the previous year[8]. - The total assets of the company as of March 31, 2025, amounted to RMB 1,753,416 million, an increase from RMB 1,692,297 million at the end of 2024[24]. - The total liabilities as of March 31, 2025, amounted to RMB 1,673,537 million, an increase of 4.9% compared to RMB 1,596,028 million as of December 31, 2024[25]. - The total liabilities and equity as of March 31, 2025, were RMB 1,753,416 million, an increase from RMB 1,692,297 million as of December 31, 2024[25]. - The total equity attributable to shareholders of the parent company decreased to RMB 79,849 million as of March 31, 2025, from RMB 96,240 million as of December 31, 2024[25]. Cash Flow - The net cash flow from operating activities decreased by 10.8% to RMB 33,588 million from RMB 37,658 million in the previous year[8]. - Total cash inflow from operating activities for the three months ended March 31, 2025, was RMB 72,710 million, an increase from RMB 61,713 million in the same period of 2024, representing a growth of 17.8%[28]. - Cash outflow from operating activities totaled RMB 39,122 million, compared to RMB 24,055 million in the prior year, indicating a significant increase of 62.8%[28]. - Net cash flow from operating activities was RMB 33,588 million, down from RMB 37,658 million year-over-year, reflecting a decrease of 10.4%[28]. - Cash inflow from investment activities reached RMB 203,951 million, up from RMB 145,063 million in the previous year, marking an increase of 40.5%[29]. - Cash outflow from investment activities was RMB 229,217 million, compared to RMB 136,801 million in the same period of 2024, representing an increase of 67.4%[29]. - Net cash flow from investment activities was negative at RMB 25,266 million, a decline from a positive RMB 8,262 million in the prior year[29]. - Cash inflow from financing activities totaled RMB 9,947 million, significantly higher than RMB 805 million in the same period of 2024[29]. - Cash outflow from financing activities was RMB 15,032 million, down from RMB 43,244 million year-over-year, indicating a decrease of 65.3%[29]. - The net increase in cash and cash equivalents for the period was RMB 3,212 million, compared to RMB 3,567 million in the previous year[29]. - The ending balance of cash and cash equivalents was RMB 41,644 million, up from RMB 25,355 million as of March 31, 2024, reflecting a growth of 64.3%[29]. Investment Performance - The annualized total investment return rate for the first quarter of 2025 was 5.7%, while the annualized comprehensive investment return rate was 2.8%[21]. - The investment income for the three months ended March 31, 2025, was RMB 9,772 million, a significant recovery from a loss of RMB 1,719 million in the same period of 2024[26].

南方财经全媒体记者 林汉垚 北京报道 2025年4月，孙俪主演的职场剧《蛮好的人生》在央视八套热播，剧中以保险行业为叙事核心，展现了 一名39岁保险从业者胡曼黎（孙俪饰）在职业与人生困境中的突围。剧中女主角保险销售胡曼黎为促成 大单在客户不知情情况下赠送意外险，甚至要求理赔部门开后门处理理赔等夸张剧情引发从业者质疑。 几乎同步，国家金融监管总局于4月18日发布《关于推动深化人身保险行业个人营销体制改革的通知》 （以下简称《通知》），通过制度规范督促保险公司加强对保险销售人员的约束和引导，推动个人代理 渠道转型升级，剧中胡曼黎所展现的行业乱象在现实中正在被政策顶层设计所纠正。 《蛮好的人生》撕开行业遮羞布 《蛮好的人生》中，胡曼黎自掏腰包为客户父亲投保五年，并在客户父亲意外骨折后为其理赔最终拿下 客户大额保单的剧情被业内人士痛批细节失真。但胡曼黎通过送礼、为客户提供"保姆式服务"获得保单 等戏剧化桥段却暴露了传统代理人模式以人情营销掩盖专业短板，以短期业绩牺牲长期信任的痼疾。 据了解，在现实生活中，代理人制度在1992年由友邦保险引入，随后，该制度被国内险企快速复制。 1994年，中国平安率先引入个人保险代理人 ...

Group 1 - The top three companies with the highest short positions are WuXi AppTec (02359), Ganfeng Lithium (01772), and Vanke Enterprises (02202), with short ratios of 15.63%, 14.23%, and 13.24% respectively [1][2] - The company with the largest increase in short positions is China Ruifeng (00136), which saw an increase of 2.52%, followed by Vanke Enterprises (02202) with an increase of 1.49%, and Rongchang Biologics (09995) with an increase of 1.18% [1][2] - The companies with the largest decrease in short positions include Zai Ding Pharmaceuticals (09688) with a decrease of 1.31%, Midea Group (00300) with a decrease of 0.80%, and Kanglong Chemical (03759) with a decrease of 0.76% [1][3] Group 2 - The latest short position data shows that the short ratio for WuXi AppTec decreased from 6168.69 million shares to 6050.95 million shares, while Ganfeng Lithium decreased from 5893.42 million shares to 5743.15 million shares [2] - The short ratio for Vanke Enterprises increased from 259 million shares to 292 million shares, indicating a growing bearish sentiment [2] - Other notable companies with significant changes in short positions include ZTE Corporation (00763) and Brilliance China Automotive (01114), with short ratios of 12.54% and 12.18% respectively [2]